Isolation, Identification, and Antibiotics Susceptibility Determination of Proteus Species Obtained from Various Clinical Specimens in Erbil City
Keywords:Antibiotic resistance, Erbil city, Proteus hauseri, Proteus species, VITEK 2
Fifty-two Proteus isolates, (47) Proteus mirabilis, (4) Proteus vulgaris, and (1) Proteus hauseri are being isolated from (200) clinical specimens taken from patients admitted to different hospitals in Erbil city/Kurdistan region of Iraq. Specimens were of urine, wounds swabs, burn swabs, vaginal swabs, ear swabs, eye swabs, and sputum. All isolates were identified depending on cultural, morphological, biochemical characteristics, and confirmatory VITEK 2 system. Furthermore, VITEK 2 (antibiotic susceptibility testing) panel was used to determine the antibiotic susceptibility of Proteus isolates, and the results showed that all isolates were entirely resistant to tetracycline and tigecycline (100%), but sensitive to meropenem. Furthermore, the present study reported a case of rare Proteus species – P. hauseri – isolated from a patient with urinary tract infection in Erbil City which characterized by no swarming on blood agar.
Adamus-Bialek, W., E. P. Parniewski. and W. Kaca. 2013. Comparison of antibiotic resistance patterns in collections of Escherichia coli and Proteus mirabilis uropathogenic strains. Mol. Biol. Rep. 40(4): 3429-3435.
Ahmed, D. A. 2015. Prevalence of Proteus spp. in some hospitals in Baghdad City. Iraqi J. Sci. 56(1): 665-672.
Al-Bassam, W. W. and A. K. Al-Kazaz. 2013. The isolation and characterization of Proteus mirabilis from different clinical samples. J. Biotechnol. Res. Center. 7(2): 24-30.
Al-Duliami, A. A., N. G. Nauman, A. S. Hasam and Z. H. Al-Azawi. 2011. Virulence factors of Proteus mirabilis isolated from patients otitis media in Baquba and its peripheries. Diyala J. Med. 1(1): 69-75.
Auwaerter, P. 2008. Antibiotic Guide. Johns Hopkins ABX (Antibiotic) Guide, Baltimore, MD.
Bahashwan, S. A. and H. M. El Shafey. 2013. Antimicrobial resistance patterns of Proteus isolates from clinical specimens. Eur. Sci. J. 9(27): 188-202.
Betty, A. F., D. F. Sahm and A. S. Weissfeld. 2007. Bailey and Scott’s Diagnostic Microbiology. 12th ed. Mosby, Inc., Elsevier Inc., Missouri.
Boucher, H. W., G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert and L. B. Rice. 2009. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48(1): 1-12.
Dadheech, T., R. Vyas and V. Rastogi. 2015. Antibiotics Resistance of aerobic bacterial isolates of Proteus mirabilis from sick layer chickens infected with septicemia and salinities in Ajmer region of Rajasthan. World J. Pharm. Pharm. Sci. 4(7): 2002-2011.
De Francesco, M. A., G. Ravizzola, L. Peroni, R. Negrini and N. Manca. 2007. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resistance of common uropathogens. Med. Sci. Monit.
Feglo, P. K. S., Y. Gbedema, S. N. A. Quay, Y. Adu-Sarkodie and C. O. Okrah. 2010. Occurrence, species distribution and antibitics resistance of Proteus isolates: A case study at the Komfo Anokye teaching hospital in Ghana.
Int. J. Pharm. Sci. Res. 1(9): 347-352.
Gonzalez, G. and M. S. Bronze. 2018. Proteus Infections: Background, Pathophysiology, Epidemiology. Available from:http://www.emedicine.medscape.com/article/226434-overview. [Last accessed on 2018 Sep 13].
Hall, R. M. and C. M. Collis. 1998. Antibiotic resistance in gramnegative bacteria: The role of gene cassettes and integrons. Drug Resist. Updat. 1: 109-119.
Hickman, F. W., A. G. Steigerwalt, J. J. 3rd Farmer and D. J. Brenner. 1982. Identification of Proteus penneri sp. Nov., formerly known as Proteus vulgaris indole negative or Proteus vulgaris biogroup 1. J. Clin. Microbiol. 15: 1097-1102.
Jacobsen, S. M., D. J. Stickler, H. L. T. Mobley and M. E. Shirtliff. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21(1): 26-59.
Janda, J. AbM. Bott, S.L. Khashe, S. Probert, W.,2006. Biochemical identification and characterization of DNA groups within Proteus vulgaris complex. J. Clin. Microbiol. 39(4): 1231-1234.
Jones, R., B. A. Vincent and W. B. Saunders. 2003. Bacteraemia, England, Wales and Northern Ireland. Commun. Dis. Rep. CDR Wkly. 15(34).
Kibret, M. and B. Abera. 2014. Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie health research laboratory, Ethiopia. Asian Pac. J. Trop. Biomed. 4: 164-168.
Latif, B., S. Z. Aleabdyn and I. Ahmed. 2017. A Comparative bacteriological and molecular study on some virulence factor of Proteus spp isolated from clinical and environment specimens. Int. J. Curr. Res. Acad. Rev. 5(5): 26-33.
Mordi, R. M. and M. I. Momoh. 2009. Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr. J. Biotechnol. 8(5): 725-730.
Naz, S. A. and S. A. Rasool. 2013. Isolation, production and characterization of bacteriocin produced by strains from indigenous environments. Pak. J. Bot., 45(1): 261-267.
Newman, M., E. A. Frimpong, A. Samoah-Adu and E. Sampane-Donkor. 2006. Resistance to Antimicrobial Drugs
in Ghana. Ghanaian-Dutch Collaboration for Health Research and Development, Project No. 2001/GD/07, Technical Report Series No. 5. p1-19.
Nita, P., N. Sharma, R. Sharma, S. Hooja and R. K. Maheshwari. 2014. Prevalence of multidrug (MDR) and extensively drug resistant (XDR) Proteus species in a tertiary care hospital, India. J. Curr. Microbiol. Appl. Sci. 3(10): 243-252.
O’Hara, C., F. W. Brenner and J. M. Miller. 2000a. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin. Microbiol. Rev. 13: 534-546.
O’Hara, C., F. W. Brenner, A. G. Steigerwalt, B. C. Hill, B. P. Holmes, A. D. Grimont, P. M. Hawkey, J. L. Penner, J. M. Miller and D. J. Brenner. 2000b. Classification of Proteus vulgaris biogroup 3 with recognition of Proteus hauseri sp. Nov., nom. rev. and unnamed Proteus genomo species 4, 5 and 6. Int. J. Syst. Evol. Microbiol. 50: 1869-1875.
Orett, F. A. 1999. Prevalence of Proteus species in urinary tract infections in a regional hospital in Trinidad. Zhonghua Yi Xue Za Zhi (Taipei). 62: 438-442.
Ostwal, K., P. Shah, L. Rebecca, N. Shaikh and K. Inole. 2016. A tale of two novel Proteus species Proteus hauseri and Proteus penneri. Int. J. Curr. Microbiol. Appl. Sci. 5(5): 84-89.
Pandey, J. K. and A. K. S. Tyagi. 2013. Prevalence of Proteus species in clinical samples, antibiotic sensitivity pattern and ESBL production. Int. J. Curr. Microbiol. Appl. Sci. 2(10): 253-261.
Reslinski, A., E. Gospodarek and A. Mikucka. 2005. Prevalence of multi-drug resistant Proteus species in clinical specimens and their susceptibility to antibiotics. Med. Dosw. Micribial. 57(2): 175-184.
Rosalski, A., A. Torzewska, M. Moryl, I. Kwil, A. Maszewska and A. Ostrowska. 2012. Proteus sp. an opportunistic bacterial pathogen-classification, swarming growth, clinical significance and virulence factors. Folia Biol. Oecol. 8(1): 1-17.
Singla, P., J. Sangwan, S. Garg, S. and U. Chaudhary. 2015. Prevalence and antibiogram of multidrug resistant uropathogenic isolates of Proteus mirabilis in a teaching tertiary care hospital. Int. J. Curr. Microbiol. Appl. Sci. 4(12): 675-682.
Yah, S. C., N. O. Egbanfona, S. Oranusi and A. M. Abouo. 2001. Widespread plasmid resistance genes among Proteus species in diabetic wounds of patients in Ahmadu Bello University Teaching Hospital (ABUTH) Zaria. Afr. J. Biotechnol. 6(15): 1757-1762.
How to Cite
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).